Scientist and founder of AtPoint working on stem cell therapeutics and leveraging innovative biotechnologies and devices for same-day personalized treatments at the point-of-care.Scientific contribution:-A co-investigator on an investigational new drug (IND) status from FDA for a phase 0/I clinical trial on the use of allogenic mesenchymal stem cells for recurrent glioblastoma (Mayo Clinic)- Optimized a clinical protocol for the acquisition and administration of adipose-derived cellular products using a semi-automated table-top device in Phase I clinical trial for OA and GI fistulas. - A strong believer in the potential of human space travel and its impact on the advancement of science. In pursuit of this, I conducted research in an attempt to study the effects of microgravity on stem cell engineering potential using biodegradable cationic nanoparticles by launching nanoengineered adipose-derived stem cells on the commercial EXOS rocket.